Why Is Loteprednol Etabonate So Hard to Find? [Explained for 2026]

You just got home from the eye doctor with a prescription for Loteprednol Etabonate — maybe after cataract surgery, during allergy season, or for a bout of eye inflammation. You head to the pharmacy and hear the dreaded words: "We don't have that in stock."

Loteprednol Etabonate isn't on the FDA drug shortage list in 2026, but patients still run into real trouble finding it. Here's an honest explanation of why this steroid eye drop can be elusive — and what you can do right now to find it.

What Is Loteprednol Etabonate and Why Is It Prescribed?

Loteprednol Etabonate is a "soft" ophthalmic corticosteroid — meaning it's specifically designed to work in the eye and then break down quickly into inactive compounds so it doesn't build up in your body. It was first approved by the FDA in 1998 and is sold under several brand names:

Lotemax and Lotemax SM — for post-surgical inflammation and pain

Alrex — for seasonal allergic conjunctivitis

Eysuvis — for dry eye disease

Inveltys — high-concentration (1%) suspension for post-operative use

Ophthalmologists prescribe it frequently as a safer-profile alternative to stronger steroids because it carries a lower risk of raising intraocular pressure (IOP) compared to options like Prednisolone Acetate or Dexamethasone. When your eye doctor picks Loteprednol, there's usually a good reason — and finding a substitute requires a conversation with them, not a self-substitution.

Is There a Loteprednol Etabonate Shortage in 2026?

No — Loteprednol Etabonate is not currently on the FDA or ASHP drug shortage list in 2026. In fact, it's often recommended as an alternative for drugs that ARE in shortage, such as Difluprednate (Durezol) and Fluorometholone (FML). That's good news for the overall supply picture.

However, "not in shortage" doesn't mean "easy to find at every pharmacy." There are several real-world reasons patients still end up making multiple calls before locating their Loteprednol Etabonate prescription.

Reason 1: It's a Specialty Ophthalmic Medication, Not an Everyday Stocked Item

Loteprednol Etabonate is a specialty eye medication. Unlike common medications like blood pressure pills or antibiotics, pharmacies don't stock specialty ophthalmic drugs in large quantities because demand is more unpredictable. A CVS or Walgreens near a high-volume cataract surgery practice may carry it routinely. One in a neighborhood without nearby ophthalmologists may not order it at all.

This is especially true for less common formulations like Lotemax SM (0.38% gel), Inveltys (1% suspension), and Eysuvis (0.25% suspension for dry eye). The standard generic 0.5% suspension is more widely stocked, but you may still need to call around.

Reason 2: Multiple Formulations Create Confusion at the Pharmacy Counter

Loteprednol Etabonate comes in at least seven distinct formulations — different concentrations (0.2%, 0.25%, 0.38%, 0.5%, 1%) and different vehicle types (suspension, gel, ointment). When a pharmacist checks the shelf for "Loteprednol," they might find one formulation but not the one your prescription specifies.

Your pharmacist cannot legally substitute one concentration or formulation for another without explicit prescriber authorization. So even if a nearby pharmacy has Lotemax 0.5% suspension in stock, that doesn't help you if your prescription is for Lotemax SM gel or Alrex 0.2%. Always confirm the exact formulation when calling around.

Reason 3: Brand Versions Are Expensive and Often Not Covered by Insurance

Brand-name Lotemax Gel retails for around $315 per bottle, and Lotemax Ointment can reach over $440 without insurance. Most insurance plans — including many Medicare Part D plans — do not cover brand-name Loteprednol formulations, particularly the newer ones like Lotemax SM and Eysuvis.

When pharmacies check real-time insurance adjudication and see that a medication isn't covered or requires prior authorization, they sometimes tell patients it's unavailable or there's a problem — when really it's a coverage issue, not a supply issue. Knowing the difference matters for how you approach finding it.

Reason 4: Not All Pharmacies Carry All Ophthalmic Brands

Eysuvis (loteprednol 0.25% for dry eye) and Inveltys (loteprednol 1%) are brand-name formulations with no generic equivalent yet. Smaller chain pharmacies and independent drugstores often don't stock niche brands unless they have consistent local demand. If your prescription is for one of these specific brands, you may need to seek out pharmacies that work closely with ophthalmology practices or specialty eye care centers.

What Should You Do Right Now If You Can't Find It?

The fastest approach is to use medfinder — a service that calls pharmacies near you to check who has your exact medication in stock. Instead of spending an hour on hold with different pharmacies, medfinder does that work for you and texts you the results.

Other strategies that work:

Ask your surgeon's or doctor's office pharmacy: Ophthalmology practices often work with in-office dispensaries or preferred pharmacies that reliably stock post-op eye drops.

Try an independent pharmacy: Independent pharmacies often use different wholesalers than chains and can place special orders, sometimes for next-day pickup.

Ask about the generic: Generic Loteprednol Etabonate 0.5% suspension and gel are widely available and much cheaper. Ask your doctor if substituting the generic is appropriate for your prescription.

Use a discount coupon: GoodRx and SingleCare coupons can bring the price of generic Loteprednol 0.5% suspension to under $55 at many pharmacies.

What If My Insurance Won't Cover It?

If insurance is the barrier, Bausch + Lomb offers the Bausch + Lomb Access Program for their brand-name Lotemax products. Commercially insured patients may pay as little as $25 per prescription. You can enroll at lotemaxsm.com/patient/savings or by calling 1-866-693-4880.

Uninsured patients should ask their doctor if generic Loteprednol 0.5% suspension or gel is an appropriate substitution — the generic version is the same active ingredient at a fraction of the cost.

The Bottom Line

Loteprednol Etabonate is not in shortage in 2026, but specialty ophthalmic medications require more searching than everyday drugs. The good news: solutions exist. Use medfinder to locate a pharmacy with your exact formulation in stock, ask about the generic, and explore savings programs if cost is the issue. For step-by-step strategies, read our guide on how to find Loteprednol Etabonate in stock near you.